UK markets closed

Amplia Therapeutics Limited (ATX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0700+0.0030 (+4.48%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Operating expenses
Research development
3,352
4,687
3,772
2,212
1,072
Selling general and administrative
2,595
2,408
1,697
1,349
1,062
Total operating expenses
6,406
7,475
5,627
3,874
2,257
Operating income or loss
-6,406
-7,475
-5,627
-3,874
-2,257
Interest expense
84.337
53.848
1.15
-
-
Total other income/expenses net
1,869
1,189
1,983
1,591
34.227
Income before tax
-4,460
-6,242
-3,644
-2,281
-2,219
Income tax expense
0
0
0
0
0
Income from continuing operations
-4,460
-6,242
-3,644
-2,281
-2,219
Net income
-4,460
-6,242
-3,644
-2,281
-2,219
Net income available to common shareholders
-4,460
-6,242
-3,644
-2,281
-2,219
Basic EPS
-0.02
-0.03
-0.02
-0.02
-0.04
Diluted EPS
-0.02
-0.03
-0.02
-0.02
-0.04
Basic average shares
199,615
199,584
149,757
98,467
54,490
Diluted average shares
199,615
199,584
149,757
98,467
54,490